Teva Recalls Linezolid Injection Bags Due to Sterility Concerns
Teva North America is recalling 546 bags of Linezolid Injection due to potential leaking that compromises sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or infection.
Plain-English summary
Teva North America is recalling 546 bags of Linezolid Injection, 600 mg/300 mL Single use container bags. The product is packaged in boxes of 10 bags and is available by prescription only. The specific lot number is 2520715, with an expiration date of 7/17.
The recall was initiated due to a lack of assurance of sterility caused by the potential for the bags to leak. This defect could compromise the safety of the medication for patients.
The affected product was distributed nationwide. Healthcare providers and patients should stop using the recalled product and contact their pharmacist or healthcare provider for a replacement or further instructions.
The recalled product
- Product
- Linezolid Injection, 600 mg/300 mL Single use container bags (NDC 0703-9060-31), packaged in 10 x 300 mL Single Use Container bags per Box Pack (NDC 0703-9060-33), Rx only, Manufactured In Hungary By: Teva Pharmaceutical Works Ltd., Hungary, H-2100 Godollo, Tancsics M. ut 82 Hung
- Manufacturer
- Teva North America
- Category
- Drug — Injectable
- Affected units
- 546
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 2520715
- Exp Date: 7/17
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Teva North America
See all →- ModerateTeva Recalls Claravis Isotretinoin Capsules Due to Impurity Failures
FDA (Drugs) · 2016-10-12
- ModerateTeva Recalls Ondansetron Injection Vials Due to Manufacturing Deviations
FDA (Drugs) · 2016-09-14
- ModerateTeva Recalls Eptifibatide Injection Vials Due to Manufacturing Deviations
FDA (Drugs) · 2016-09-14
- ModerateTeva Recalls Argatroban Injection Due to Manufacturing Deviations
FDA (Drugs) · 2016-09-14
- SevereTeva Recalls Linezolid Injection Due to Manufacturing Deviations
FDA (Drugs) · 2016-09-14
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29